{
 "drug": "Clindamycin Phosphate Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "03/21/2023",
 "dayN": 1253,
 "cat": "Anti-Infective",
 "companies": [
  "Baxter Healthcare",
  "Sagent Pharmaceuticals",
  "Pfizer Inc.",
  "Sandoz Inc."
 ],
 "reasons": [
  "Discontinuation of the manufacture of the drug",
  "Other",
  "Demand increase for the drug"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-9545-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA208083"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-9545",
     "0338-9549",
     "0338-9553"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b0a47c5e-911b-4b12-a0d1-a4425f173eec"
    ],
    "spl_set_id": [
     "44fa506b-90ac-42de-831b-5f3f1a500fc0"
    ],
    "package_ndc": [
     "0338-9545-50",
     "0338-9545-24",
     "0338-9549-50",
     "0338-9549-24",
     "0338-9553-50",
     "0338-9553-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "25021-115-02",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "866-625-1618",
   "availability": "Limited Availability",
   "related_info": "Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line",
   "openfda": {
    "application_number": [
     "ANDA090108"
    ],
    "brand_name": [
     "CLINDAMYCIN"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-115"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737578",
     "1737581"
    ],
    "spl_id": [
     "4662502b-ce7c-4278-854d-cf8632ac9b83"
    ],
    "spl_set_id": [
     "7a6967b3-5563-4bed-9eee-d400f800e799"
    ],
    "package_ndc": [
     "25021-115-02",
     "25021-115-04",
     "25021-115-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-4073-04",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-4073",
     "0009-3051",
     "0009-5095"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL) (NDC 0009-4073-04)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "25021-115-06",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "866-625-1618",
   "availability": "Limited Availability",
   "related_info": "Selling through remaining short-dated inventory (Dec 2026), API not available, Exiting product line",
   "openfda": {
    "application_number": [
     "ANDA090108"
    ],
    "brand_name": [
     "CLINDAMYCIN"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-115"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737578",
     "1737581"
    ],
    "spl_id": [
     "4662502b-ce7c-4278-854d-cf8632ac9b83"
    ],
    "spl_set_id": [
     "7a6967b3-5563-4bed-9eee-d400f800e799"
    ],
    "package_ndc": [
     "25021-115-02",
     "25021-115-04",
     "25021-115-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-3051-02",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3051",
     "0009-4073",
     "0009-5095"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL) (NDC 0009-3051-02)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-3814-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Limited Availability",
   "related_info": "Estimated recovery: October 2026",
   "openfda": {
    "application_number": [
     "ANDA208084"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-3814",
     "0338-3410",
     "0338-3612"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "c8906ab2-37d2-4fde-9784-0442bf7b9565"
    ],
    "spl_set_id": [
     "78832ac6-04c5-45e0-ae4d-f56d7920dda9"
    ],
    "package_ndc": [
     "0338-3410-50",
     "0338-3410-24",
     "0338-3612-50",
     "0338-3612-24",
     "0338-3814-50",
     "0338-3814-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-0902-18",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0902",
     "0009-0870",
     "0009-0775",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "25021-115-04",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "866-625-1618",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA090108"
    ],
    "brand_name": [
     "CLINDAMYCIN"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Sagent Pharmaceuticals"
    ],
    "product_ndc": [
     "25021-115"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737578",
     "1737581"
    ],
    "spl_id": [
     "4662502b-ce7c-4278-854d-cf8632ac9b83"
    ],
    "spl_set_id": [
     "7a6967b3-5563-4bed-9eee-d400f800e799"
    ],
    "package_ndc": [
     "25021-115-02",
     "25021-115-04",
     "25021-115-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)",
   "company_name": "Sagent Pharmaceuticals",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-0775-26",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0775",
     "0009-0870",
     "0009-0902",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-3410-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA208084"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-3410",
     "0338-3612",
     "0338-3814"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "c8906ab2-37d2-4fde-9784-0442bf7b9565"
    ],
    "spl_set_id": [
     "78832ac6-04c5-45e0-ae4d-f56d7920dda9"
    ],
    "package_ndc": [
     "0338-3410-50",
     "0338-3410-24",
     "0338-3612-50",
     "0338-3612-24",
     "0338-3814-50",
     "0338-3814-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-4073-04",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-4073",
     "0009-3051",
     "0009-5095"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0781-3288-09",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "800-525-8747",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA201692"
    ],
    "brand_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "generic_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "manufacturer_name": [
     "Sandoz Inc"
    ],
    "product_ndc": [
     "0781-3288",
     "0781-3289",
     "0781-3290"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"
    ],
    "spl_set_id": [
     "231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"
    ],
    "package_ndc": [
     "0781-3288-91",
     "0781-3288-09",
     "0781-3289-91",
     "0781-3289-09",
     "0781-3290-91",
     "0781-3290-09"
    ],
    "nui": [
     "N0000009982",
     "N0000175443",
     "M0515779",
     "N0000175731"
    ],
    "pharm_class_pe": [
     "Decreased Sebaceous Gland Activity [PE]",
     "Neuromuscular Blockade [PE]"
    ],
    "pharm_class_epc": [
     "Lincosamide Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Lincosamides [CS]"
    ],
    "unii": [
     "3U02EL437C"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)",
   "company_name": "Sandoz Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-0902-18",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0902",
     "0009-0870",
     "0009-0775",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-9549-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA208083"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-9549",
     "0338-9545",
     "0338-9553"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b0a47c5e-911b-4b12-a0d1-a4425f173eec"
    ],
    "spl_set_id": [
     "44fa506b-90ac-42de-831b-5f3f1a500fc0"
    ],
    "package_ndc": [
     "0338-9545-50",
     "0338-9545-24",
     "0338-9549-50",
     "0338-9549-24",
     "0338-9553-50",
     "0338-9553-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0781-3289-09",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "800-525-8747",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA201692"
    ],
    "brand_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "generic_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "manufacturer_name": [
     "Sandoz Inc"
    ],
    "product_ndc": [
     "0781-3289",
     "0781-3288",
     "0781-3290"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"
    ],
    "spl_set_id": [
     "231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"
    ],
    "package_ndc": [
     "0781-3288-91",
     "0781-3288-09",
     "0781-3289-91",
     "0781-3289-09",
     "0781-3290-91",
     "0781-3290-09"
    ],
    "nui": [
     "N0000009982",
     "N0000175443",
     "M0515779",
     "N0000175731"
    ],
    "pharm_class_pe": [
     "Decreased Sebaceous Gland Activity [PE]",
     "Neuromuscular Blockade [PE]"
    ],
    "pharm_class_epc": [
     "Lincosamide Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Lincosamides [CS]"
    ],
    "unii": [
     "3U02EL437C"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)",
   "company_name": "Sandoz Inc.",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "72572-074-24",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "800-525-8747",
   "availability": "Available",
   "related_info": "Civica Label",
   "openfda": {
    "application_number": [
     "ANDA201692"
    ],
    "brand_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "generic_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "manufacturer_name": [
     "Civica, Inc."
    ],
    "product_ndc": [
     "72572-074",
     "72572-076"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN"
    ],
    "rxcui": [
     "309335",
     "309336"
    ],
    "spl_id": [
     "4711c157-19a5-4886-b468-8739876e67be"
    ],
    "spl_set_id": [
     "80217bd6-2bc4-401c-9345-22532b36a24f"
    ],
    "package_ndc": [
     "72572-074-01",
     "72572-074-24",
     "72572-076-01",
     "72572-076-24"
    ],
    "nui": [
     "N0000009982",
     "N0000175443",
     "M0515779",
     "N0000175731"
    ],
    "pharm_class_pe": [
     "Decreased Sebaceous Gland Activity [PE]",
     "Neuromuscular Blockade [PE]"
    ],
    "pharm_class_epc": [
     "Lincosamide Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Lincosamides [CS]"
    ],
    "unii": [
     "3U02EL437C"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)",
   "company_name": "Sandoz Inc.",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-0870-26",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0870",
     "0009-0775",
     "0009-0902",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-9553-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA208083"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-9553",
     "0338-9545",
     "0338-9549"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b0a47c5e-911b-4b12-a0d1-a4425f173eec"
    ],
    "spl_set_id": [
     "44fa506b-90ac-42de-831b-5f3f1a500fc0"
    ],
    "package_ndc": [
     "0338-9545-50",
     "0338-9545-24",
     "0338-9549-50",
     "0338-9549-24",
     "0338-9553-50",
     "0338-9553-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)",
   "company_name": "Baxter Healthcare",
   "status": "Current"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-3051-02",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-3051",
     "0009-4073",
     "0009-5095"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "06/01/2026",
   "update_type": "New",
   "initial_posting_date": "06/01/2026",
   "package_ndc": "0009-5095-06",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "844-646-4398",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-5095",
     "0009-3051",
     "0009-4073"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "06/01/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)",
   "company_name": "Pfizer Inc.",
   "status": "To Be Discontinued"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0338-3612-50",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "888-229-0001",
   "availability": "Unavailable",
   "related_info": "Estimated recovery: October 2026",
   "openfda": {
    "application_number": [
     "ANDA208084"
    ],
    "brand_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Baxter Healthcare Company"
    ],
    "product_ndc": [
     "0338-3612",
     "0338-3410",
     "0338-3814"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "c8906ab2-37d2-4fde-9784-0442bf7b9565"
    ],
    "spl_set_id": [
     "78832ac6-04c5-45e0-ae4d-f56d7920dda9"
    ],
    "package_ndc": [
     "0338-3410-50",
     "0338-3410-24",
     "0338-3612-50",
     "0338-3612-24",
     "0338-3814-50",
     "0338-3814-24"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)",
   "company_name": "Baxter Healthcare",
   "shortage_reason": "Other",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0781-3290-09",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "800-525-8747",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA201692"
    ],
    "brand_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "generic_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "manufacturer_name": [
     "Sandoz Inc"
    ],
    "product_ndc": [
     "0781-3290",
     "0781-3288",
     "0781-3289"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN"
    ],
    "rxcui": [
     "309335",
     "309336",
     "309339"
    ],
    "spl_id": [
     "b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"
    ],
    "spl_set_id": [
     "231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"
    ],
    "package_ndc": [
     "0781-3288-91",
     "0781-3288-09",
     "0781-3289-91",
     "0781-3289-09",
     "0781-3290-91",
     "0781-3290-09"
    ],
    "nui": [
     "N0000009982",
     "N0000175443",
     "M0515779",
     "N0000175731"
    ],
    "pharm_class_pe": [
     "Decreased Sebaceous Gland Activity [PE]",
     "Neuromuscular Blockade [PE]"
    ],
    "pharm_class_epc": [
     "Lincosamide Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Lincosamides [CS]"
    ],
    "unii": [
     "3U02EL437C"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)",
   "company_name": "Sandoz Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-0870-26",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Next Delivery and Estimated Recovery: December 2028",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0870",
     "0009-0775",
     "0009-0902",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Demand increase for the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "72572-076-24",
   "generic_name": "Clindamycin Phosphate Injection",
   "contact_info": "800-525-8747",
   "availability": "Available",
   "related_info": "Civica Label",
   "openfda": {
    "application_number": [
     "ANDA201692"
    ],
    "brand_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "generic_name": [
     "CLINDAMYCIN IN 5 PERCENT DEXTROSE"
    ],
    "manufacturer_name": [
     "Civica, Inc."
    ],
    "product_ndc": [
     "72572-076",
     "72572-074"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN"
    ],
    "rxcui": [
     "309335",
     "309336"
    ],
    "spl_id": [
     "4711c157-19a5-4886-b468-8739876e67be"
    ],
    "spl_set_id": [
     "80217bd6-2bc4-401c-9345-22532b36a24f"
    ],
    "package_ndc": [
     "72572-074-01",
     "72572-074-24",
     "72572-076-01",
     "72572-076-24"
    ],
    "nui": [
     "N0000009982",
     "N0000175443",
     "M0515779",
     "N0000175731"
    ],
    "pharm_class_pe": [
     "Decreased Sebaceous Gland Activity [PE]",
     "Neuromuscular Blockade [PE]"
    ],
    "pharm_class_epc": [
     "Lincosamide Antibacterial [EPC]"
    ],
    "pharm_class_cs": [
     "Lincosamides [CS]"
    ],
    "unii": [
     "3U02EL437C"
    ]
   },
   "update_date": "08/18/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)",
   "company_name": "Sandoz Inc.",
   "status": "Current"
  },
  {
   "update_type": "Revised",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-5095-06",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Unavailable",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-5095",
     "0009-3051",
     "0009-4073"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"
    ],
    "spl_set_id": [
     "a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"
    ],
    "package_ndc": [
     "0009-3051-01",
     "0009-3051-02",
     "0009-4073-03",
     "0009-4073-04",
     "0009-5095-05",
     "0009-5095-06"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL) (NDC 0009-5095-06)",
   "company_name": "Pfizer Inc.",
   "shortage_reason": "Discontinuation of the manufacture of the drug",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "03/21/2023",
   "package_ndc": "0009-0775-26",
   "generic_name": "Clindamycin Phosphate Injection",
   "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d",
   "contact_info": "800-533-4535",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "NDA050441"
    ],
    "brand_name": [
     "CLEOCIN PHOSPHATE"
    ],
    "generic_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "manufacturer_name": [
     "Pharmacia & Upjohn Company LLC"
    ],
    "product_ndc": [
     "0009-0775",
     "0009-0870",
     "0009-0902",
     "0009-0728",
     "0009-3124",
     "0009-3447",
     "0009-3381",
     "0009-3375",
     "0009-3382",
     "0009-6582"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR",
     "INTRAVENOUS"
    ],
    "substance_name": [
     "CLINDAMYCIN PHOSPHATE"
    ],
    "rxcui": [
     "205964",
     "309335",
     "309336",
     "309339",
     "685574",
     "685576",
     "685578",
     "706461",
     "1737244",
     "1737245",
     "1737578",
     "1737579",
     "1737581",
     "1737582"
    ],
    "spl_id": [
     "fa11e62e-4625-4e9c-8676-f318b1cb890f"
    ],
    "spl_set_id": [
     "05a75685-0af5-407c-ac57-e380c882b49d"
    ],
    "package_ndc": [
     "0009-0870-21",
     "0009-0870-26",
     "0009-0775-20",
     "0009-0775-26",
     "0009-0902-11",
     "0009-0902-18",
     "0009-0728-05",
     "0009-0728-09",
     "0009-3124-01",
     "0009-3124-03",
     "0009-3447-01",
     "0009-3447-03",
     "0009-3381-01",
     "0009-3381-02",
     "0009-3375-01",
     "0009-3375-02",
     "0009-3382-01",
     "0009-3382-02",
     "0009-6582-02",
     "0009-6582-01"
    ],
    "unii": [
     "EH6D7113I8"
    ]
   },
   "update_date": "08/07/2026",
   "therapeutic_category": [
    "Anti-Infective"
   ],
   "dosage_form": "Injection",
   "presentation": "Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)",
   "company_name": "Pfizer Inc.",
   "status": "Current"
  }
 ]
}